Filing Details

Accession Number:
0000950170-25-081041
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-06-03 16:46:15
Reporting Period:
2025-06-02
Filing Date:
2025-06-03
Accepted Time:
2025-06-03 16:46:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1880438 An2 Therapeutics Inc. ANTX Pharmaceutical Preparations (2834) 820606654
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1914503 Eric Easom C/O An2 Therapeutics, Inc.
1800 El Camino Real, Suite D
Menlo Park CA 94027
Chief Executive Officer No No No No
Transaction Summary
Purchased: 10,000 shares Avg. Price: $1.07 Total Value: $10,665.00
Number of Shares After Transactions: 256,380 shares
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2025-06-02 10,000 $1.07 256,380 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,065,766 Indirect See Footnote
Common Stock 97,058 Indirect See Footnote
Common Stock 97,058 Indirect See Footnote
Footnotes
  1. This price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions reported on this line ranged from $1.05 to $1.0699 per share. Upon request by the Commission staff, the issuer or a security holder of the issuer, the reporting person will undertake to provide full information regarding the number of shares sold at each separate price.
  2. Includes (i) 145,250 restricted stock units ("RSUs") which vest as follows: 1/4th of the shares vests annually over four years from January 1, 2025, subject to the Reporting Person's continuous service as of such date and (ii) a balance of 99,000 RSUs which vest as follows: 1/4th of the shares vests annually over four years from January 1, 2024, subject to the Reporting Person's continuous service as of each such date.
  3. Consists of shares of Common Stock held by the Easom Living Trust dated August 21, 2019.
  4. Consists of shares of Common Stock held by the C. Easom Irrevocable Trust dated October 8, 2021.
  5. Consists of shares of Common Stock held by the Jude Easom Irrevocable Trust dated October 8, 2021.